Scopus files IPO prospectus on Nasdaq

Scopus Video Networks develops digital video networking products that enable network operators to offer advanced video services to their subscribers.

By AVI KRAWITZ
November 21, 2005 07:14
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Scopus Video Networks filed over the weekend a draft prospectus for an initial public offering (IPO) on the Nasdaq, with the intent of raising approximately $50 million, the company said in a statement. According to the prospectus, Scopus will sell up to 4.5 million shares at a price of between $10m. and $12m. per share, while the underwriters will have a 30-day option to buy a further 675,000 shares.Thomas Weisel Partners LLC will act as sole book-runner for the offering and CIBC World Markets will act as co-lead manager. Needham & Company, LLC and Oppenheimer & Co. will act as co-managers. Scopus Video Networks develops digital video networking products that enable network operators to offer advanced video services to their subscribers.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS